PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.\', \'British Columbia Center on Substance Use, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Yale School of Nursing, Orange, Connecticut.\', \'Vassar College, Poughkeepsie, New York.\', \'Sections of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.\', \'Faculty of Pharmacy, Université de Montréal, Montréal, Canada.\', \'VA Connecticut Healthcare System, West Haven.\', \'Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2021.18223
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 34297070
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all